Small molecule · Inhibitor of protein phosphatase 2A (PPP2CA) · developed by Lixte Biotechnology Holdings
Phase 1/2Most advanced trial
1Registered trials
What is LB-100?
LB-100 is a water-soluble inhibitor of protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in cell growth control and DNA damage repair. It is studied in combination with chemotherapy or radiotherapy in ovarian clear cell carcinoma.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.